CD79B,CD19,PD-L1の差異的発現は,デノボおよび変異性CD20陰性大B細胞リンパ腫において異なる
Yuto Kaimi1,2, Yuka Takahashi1,3, Mai Takeuchi1
1Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.
Hematological oncology
|February 14, 2026
まとめ
CD20陰性大B細胞リンパ腫は,変数CD79BおよびCD19発現を示し,特にデノボ拡散大B細胞リンパ腫 (DLBCL) とプラズマ芽細胞リンパ腫では低い. プログラムされた細胞死タンパク質1/プログラムされた死リガンド1阻害剤は,新しい治療の道を提供することがあります.
科学分野:
- 血液学 ヘマトロジ
- 腫瘍学 腫瘍学
- 免疫学 免疫学とは
背景:
- CD20陰性大B細胞リンパ腫 (LBCL) は攻撃的で,リトゥキシマブ治療の選択肢がない.
- これらの患者にとって,代替的な治療目標の特定は極めて重要です.
研究 の 目的:
- CD20陰性LBCLにおけるCD79BおよびCD19発現を分析する.
- 潜在的な治療目標と治療戦略を探求する.
主な方法:
- CD20陰性LBCLの75人の患者の108個のサンプルを,CD79BおよびCD19発現のHスコアを使用して分析した.
- 腫瘍比率スコアと組み合わせた陽性スコアを使用して,プログラムされた死亡リガンド1 (PD-L1) 発現を評価しました.
主要な成果:
- CD79BとCD19は変異的に発現し,分別51%と57%のサンプルで拡散-強い発現が観察されました.
- 変換されたDLBCLと比較して,デノボCD20陰性分散型大B細胞リンパ腫 (DLBCL) の発現は著しく低下しました.
- CD79BとCD19は,プラズマプラズマリンパ腫ではしばしば陰性であった (それぞれ83%と66%).
- PD-L1は,CD79B/CD19発現が低い症例の33%で陽性であった.
結論:
- CD79BとCD19の発現は,CD20陰性LBCLでは異質であり,新規DLBCLとプラズマ芽細胞リンパ腫ではレベルが低下しています.
- プログラム細胞死タンパク質1 (PD-1) /PD-L1阻害剤は,これらの患者にとって潜在的な治療戦略です.
関連する概念動画
Cell Specific Gene Expression
16.6K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.6K
Bacterial Transformation
60.2K
In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
60.2K
PD Controller: Design
669
In automotive engineering, car suspension systems often employ Proportional Derivative (PD) controllers to enhance performance. PD controllers are utilized to adjust the damping force in response to road conditions. A controller, acting as an amplifier with a constant gain, demonstrates proportional control, with output directly mirroring input.
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
669
Negative Regulator Molecules
38.6K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.6K
Time-Domain Interpretation of PD Control
408
Proportional-Derivative (PD) control is a widely used control method in various engineering systems to enhance stability and performance. In a system with only proportional control, common issues include high maximum overshoot and oscillation, observed in both the error signal and its rate of change. This behavior can be divided into three distinct phases: initial overshoot, subsequent undershoot, and gradual stabilization.
Consider the example of control of motor torque. Initially, a positive...
Consider the example of control of motor torque. Initially, a positive...
408
iPS Cell Differentiation
3.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.2K


